These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1570834)
1. A Cys138-to-Arg substitution in the GM2 activator protein is associated with the AB variant form of GM2 gangliosidosis. Xie B; Wang W; Mahuran DJ Am J Hum Genet; 1992 May; 50(5):1046-52. PubMed ID: 1570834 [TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A. Xie B; Rigat B; Smiljanic-Georgijev N; Deng H; Mahuran D Biochemistry; 1998 Jan; 37(3):814-21. PubMed ID: 9454570 [TBL] [Abstract][Full Text] [Related]
3. A mutation in the gene of a glycolipid-binding protein (GM2 activator) that causes GM2-gangliosidosis variant AB. Schröder M; Schnabel D; Suzuki K; Sandhoff K FEBS Lett; 1991 Sep; 290(1-2):1-3. PubMed ID: 1915858 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of GM2-gangliosidosis AB variant: a novel mutation and expression in BHK cells. Schröder M; Schnabel D; Hurwitz R; Young E; Suzuki K; Sandhoff K Hum Genet; 1993 Nov; 92(5):437-40. PubMed ID: 8244332 [TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of a GM2-activator deficiency in two patients with GM2-gangliosidosis AB variant. Schepers U; Glombitza G; Lemm T; Hoffmann A; Chabas A; Ozand P; Sandhoff K Am J Hum Genet; 1996 Nov; 59(5):1048-56. PubMed ID: 8900233 [TBL] [Abstract][Full Text] [Related]
6. GM2 gangliosidosis AB variant: first case of late onset and review of the literature. Ganne B; Dauriat B; Richard L; Lamari F; Ghorab K; Magy L; Benkirane M; Perani A; Marquet V; Calvas P; Yardin C; Bourthoumieu S Neurol Sci; 2022 Nov; 43(11):6517-6527. PubMed ID: 35925454 [TBL] [Abstract][Full Text] [Related]
7. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase. Paw BH; Kaback MM; Neufeld EF Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2413-7. PubMed ID: 2522660 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system. Schwarzmann G; Wendeler M; Sandhoff K Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415 [TBL] [Abstract][Full Text] [Related]
9. Isolation of a cDNA encoding the human GM2 activator protein. Schröder M; Klima H; Nakano T; Kwon H; Quintern LE; Gärtner S; Suzuki K; Sandhoff K FEBS Lett; 1989 Jul; 251(1-2):197-200. PubMed ID: 2753159 [TBL] [Abstract][Full Text] [Related]
10. GM2 gangliosidosis associated with a HEXA missense mutation in Japanese Chin dogs: a potential model for Tay Sachs disease. Sanders DN; Zeng R; Wenger DA; Johnson GS; Johnson GC; Decker JE; Katz ML; Platt SR; O'Brien DP Mol Genet Metab; 2013 Jan; 108(1):70-5. PubMed ID: 23266199 [TBL] [Abstract][Full Text] [Related]
11. Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase. Paw BH; Moskowitz SM; Uhrhammer N; Wright N; Kaback MM; Neufeld EF J Biol Chem; 1990 Jun; 265(16):9452-7. PubMed ID: 2140574 [TBL] [Abstract][Full Text] [Related]
12. Biochemical consequences of mutations causing the GM2 gangliosidoses. Mahuran DJ Biochim Biophys Acta; 1999 Oct; 1455(2-3):105-38. PubMed ID: 10571007 [TBL] [Abstract][Full Text] [Related]
13. Isolation and expression of a full-length cDNA encoding the human GM2 activator protein. Xie B; McInnes B; Neote K; Lamhonwah AM; Mahuran D Biochem Biophys Res Commun; 1991 Jun; 177(3):1217-23. PubMed ID: 2059210 [TBL] [Abstract][Full Text] [Related]
14. The mouse gene encoding the GM2 activator protein (Gm2a): cDNA sequence, expression, and chromosome mapping. Yamanaka S; Johnson ON; Lyu MS; Kozak CA; Proia RL Genomics; 1994 Dec; 24(3):601-4. PubMed ID: 7713516 [TBL] [Abstract][Full Text] [Related]
15. GM2 gangliosidosis AB variant: clinical and biochemical studies of a Japanese patient. Sakuraba H; Itoh K; Shimmoto M; Utsumi K; Kase R; Hashimoto Y; Ozawa T; Ohwada Y; Imataka G; Eguchi M; Furukawa T; Schepers U; Sandhoff K Neurology; 1999 Jan; 52(2):372-7. PubMed ID: 9932959 [TBL] [Abstract][Full Text] [Related]
16. Over-expression of a functionally active human GM2-activator protein in Escherichia coli. Klima H; Klein A; van Echten G; Schwarzmann G; Suzuki K; Sandhoff K Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):571-6. PubMed ID: 8503891 [TBL] [Abstract][Full Text] [Related]
17. Molecular forms of GM2-activator protein. A study on its biosynthesis in human skin fibroblasts. Burg J; Banerjee A; Sandhoff K Biol Chem Hoppe Seyler; 1985 Sep; 366(9):887-91. PubMed ID: 3935131 [TBL] [Abstract][Full Text] [Related]
19. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB. Hechtman P; Gordon BA; Ng Ying Kin NM Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612 [TBL] [Abstract][Full Text] [Related]
20. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis. Martin DR; Cox NR; Morrison NE; Kennamer DM; Peck SL; Dodson AN; Gentry AS; Griffin B; Rolsma MD; Baker HJ Acta Neuropathol; 2005 Nov; 110(5):443-50. PubMed ID: 16200419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]